Hedvig Bennet1, Inês G Mollet2, Alexander Balhuizen3, Anya Medina3, Cecilia Nagorny4, Annika Bagge4, Joao Fadista5, Emilia Ottosson-Laakso5, Petter Vikman5, Marloes Dekker-Nitert5,6, Lena Eliasson2, Nils Wierup7, Isabella Artner8, Malin Fex3. 1. Lund University Diabetes Centre, Department of Clinical Sciences, Unit of Diabetes and Celiac disease, Clinical Research Centre, Jan Waldenströms gata 35, Clinical Research Centre House 91:10, Skåne University Hospital Malmö, SE-20502, Malmö, Sweden. hedvig.bennet@med.lu.se. 2. Lund University Diabetes Centre, Islet Cell Exocytosis, Malmö, Sweden. 3. Lund University Diabetes Centre, Department of Clinical Sciences, Unit of Diabetes and Celiac disease, Clinical Research Centre, Jan Waldenströms gata 35, Clinical Research Centre House 91:10, Skåne University Hospital Malmö, SE-20502, Malmö, Sweden. 4. Lund University Diabetes Centre, Molecular Metabolism, Malmö, Sweden. 5. Lund University Diabetes Centre, Diabetes and Endocrinology, Malmö, Sweden. 6. Royal Brisbane Clinical School, UQ Centre for Clinical Research, The University of Queensland, Herston, QLD, Australia. 7. Lund University Diabetes Centre, Neuroendocrine Cell Biology, Malmö, Sweden. 8. Lund University Diabetes Centre, Stem Cell Center, Biomedical Centre (BMC), Lund, Sweden.
Abstract
AIMS/HYPOTHESIS: The Gq-coupled 5-hydroxytryptamine 2B (5-HT2B) receptor is known to regulate the proliferation of islet beta cells during pregnancy. However, the role of serotonin in the control of insulin release is still controversial. The aim of the present study was to explore the role of the 5-HT2B receptor in the regulation of insulin secretion in mouse and human islets, as well as in clonal INS-1(832/13) cells. METHODS: Expression of HTR2B mRNA and 5-HT2B protein was examined with quantitative real-time PCR, RNA sequencing and immunohistochemistry. α-Methyl serotonin maleate salt (AMS), a serotonin receptor agonist, was employed for robust 5-HT2B receptor activation. Htr2b was silenced with small interfering RNA in INS-1(832/13) cells. Insulin secretion, Ca(2+) response and oxygen consumption rate were determined. RESULTS: Immunohistochemistry revealed that 5-HT2B is expressed in human and mouse islet beta cells. Activation of 5-HT2B receptors by AMS enhanced glucose-stimulated insulin secretion (GSIS) in human and mouse islets as well as in INS-1(832/13) cells. Silencing Htr2b in INS-1(832/13) cells led to a 30% reduction in GSIS. 5-HT2B receptor activation produced robust, regular and sustained Ca(2+) oscillations in mouse islets with an increase in both peak distance (period) and time in the active phase as compared with control. Enhanced insulin secretion and Ca(2+) changes induced by AMS coincided with an increase in oxygen consumption in INS-1(832/13) cells. CONCLUSIONS/ INTERPRETATION: Activation of 5-HT2B receptors stimulates GSIS in beta cells by triggering downstream changes in cellular Ca(2+) flux that enhance mitochondrial metabolism. Our findings suggest that serotonin and the 5-HT2B receptor stimulate insulin release.
AIMS/HYPOTHESIS: The Gq-coupled 5-hydroxytryptamine 2B (5-HT2B) receptor is known to regulate the proliferation of islet beta cells during pregnancy. However, the role of serotonin in the control of insulin release is still controversial. The aim of the present study was to explore the role of the 5-HT2B receptor in the regulation of insulin secretion in mouse and human islets, as well as in clonal INS-1(832/13) cells. METHODS: Expression of HTR2B mRNA and 5-HT2B protein was examined with quantitative real-time PCR, RNA sequencing and immunohistochemistry. α-Methyl serotonin maleate salt (AMS), a serotonin receptor agonist, was employed for robust 5-HT2B receptor activation. Htr2b was silenced with small interfering RNA in INS-1(832/13) cells. Insulin secretion, Ca(2+) response and oxygen consumption rate were determined. RESULTS: Immunohistochemistry revealed that 5-HT2B is expressed in human and mouse islet beta cells. Activation of 5-HT2B receptors by AMS enhanced glucose-stimulated insulin secretion (GSIS) in human and mouse islets as well as in INS-1(832/13) cells. Silencing Htr2b in INS-1(832/13) cells led to a 30% reduction in GSIS. 5-HT2B receptor activation produced robust, regular and sustained Ca(2+) oscillations in mouse islets with an increase in both peak distance (period) and time in the active phase as compared with control. Enhanced insulin secretion and Ca(2+) changes induced by AMS coincided with an increase in oxygen consumption in INS-1(832/13) cells. CONCLUSIONS/ INTERPRETATION: Activation of 5-HT2B receptors stimulates GSIS in beta cells by triggering downstream changes in cellular Ca(2+) flux that enhance mitochondrial metabolism. Our findings suggest that serotonin and the 5-HT2B receptor stimulate insulin release.
Entities:
Keywords:
Beta cell; Ca2+ oscillations; G protein-coupled receptor; Human islets of Langerhans; Insulin secretion; Mitochondrial respiration
Authors: Patricia Campos-Bedolla; Mario H Vargas; Eduardo Calixto; Patricia Segura; Nicandro Mendoza-Patiño; Alejandra Figueroa; Edgar Flores-Soto; Carlos Barajas-López; Luis M Montaño Journal: Pharmacol Res Date: 2006-09-30 Impact factor: 7.658
Authors: Kyuho Kim; Chang-Myung Oh; Mica Ohara-Imaizumi; Sangkyu Park; Jun Namkung; Vijay K Yadav; Natalia A Tamarina; Michael W Roe; Louis H Philipson; Gerard Karsenty; Shinya Nagamatsu; Michael S German; Hail Kim Journal: Endocrinology Date: 2014-11-26 Impact factor: 4.736
Authors: A Schraenen; K Lemaire; G de Faudeur; N Hendrickx; M Granvik; L Van Lommel; J Mallet; G Vodjdani; P Gilon; N Binart; P in't Veld; F Schuit Journal: Diabetologia Date: 2010-10-07 Impact factor: 10.122
Authors: Mohammad R Ebrahimkhani; Fiona Oakley; Lindsay B Murphy; Jelena Mann; Anna Moles; Maria J Perugorria; Elizabeth Ellis; Anne F Lakey; Alastair D Burt; Angela Douglass; Matthew C Wright; Steven A White; Fabrice Jaffré; Luc Maroteaux; Derek A Mann Journal: Nat Med Date: 2011-11-27 Impact factor: 53.440
Authors: Julian M Yabut; Justin D Crane; Alexander E Green; Damien J Keating; Waliul I Khan; Gregory R Steinberg Journal: Endocr Rev Date: 2019-08-01 Impact factor: 19.871
Authors: Nathan D Han; Jiye Cheng; Omar Delannoy-Bruno; Daniel Webber; Nicolas Terrapon; Bernard Henrissat; Dmitry A Rodionov; Aleksandr A Arzamasov; Andrei L Osterman; David K Hayashi; Alexandra Meynier; Sophie Vinoy; Chandani Desai; Stacey Marion; Michael J Barratt; Andrew C Heath; Jeffrey I Gordon Journal: Cell Date: 2022-06-27 Impact factor: 66.850
Authors: Luis Rodrigo Cataldo; María L Mizgier; Roberto Bravo Sagua; Fabián Jaña; César Cárdenas; Paola Llanos; Dolores Busso; Pablo Olmos; José E Galgani; José L Santos; Víctor A Cortés Journal: PLoS One Date: 2017-01-27 Impact factor: 3.240